CDC advisers to review data on Pfizer-BioNTech COVID-19 vaccine
A US Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote expected on Sunday